PD166326，≥98% (HPLC)
最近浏览商品
-
银分散液，Silver, dispersion；nanoparticles, 60 nm particle size (TEM), 0.02 mg/mL in aqueous buffer, contains sodium citrate as stabilizer -
二硫化钨量子点，Tungsten disulfide quantum dots；liquid, avg. 10nm particle size, 0.5mg/ml in H2O -
反式-橙花叔醇，trans-Nerolidol；primary reference standard -
![图片 (R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 [美罗培南中间体F9]，(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate；≥98%](https://www.bszh.cn/images/thumbs/0020388_r-4-2-4-2r3s-3-r-1-4-2-3-f9r-4-nitrobenzyl-2-diazo-4-2r3s-3-r-1-hydroxy-ethyl-4-oxoazetidin-2-yl-3-o_32.png "显示明细 (R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 [美罗培南中间体F9]，(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate；≥98%")
(R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 [美罗培南中间体F9]，(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate；≥98% -
HiScreen Capto Core 700预装柱，HiScreen Capto Core 700 (prepacked columns) -
CIN-I培养基基础，CIN-I Media base
